PFM
NTLA icon

Privium Fund Management’s Intellia Therapeutics NTLA Stock Holding History

Privium Fund Management’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-58,709
Closed -$417K – 61
2025
Q1 		$417K Buy
58,709
+31,000
+112% +$313K 0.11% 46
2024
Q4 		$323K Buy
27,709
+15,409
+125% +$240K 0.07% 52
2024
Q3 		$253K Buy
+12,300
New +$284K 0.06% 69
2024
Q2 		– Sell
-8,905
Closed -$245K – 133
2024
Q1 		$245K Hold
8,905
– – 0.07% 80
2023
Q4 		$274K Hold
8,905
– – 0.08% 65
2023
Q3 		$282K Hold
8,905
– – 0.08% 65
2023
Q2 		$364K Hold
8,905
– – 0.1% 63
2023
Q1 		$332K Buy
8,905
+1,615
+22% +$63.3K 0.11% 58
2022
Q4 		$257K Buy
7,290
+2,000
+38% +$95.1K 0.1% 66
2022
Q3 		$292K Buy
5,290
+1,250
+31% +$77.5K 0.11% 80
2022
Q2 		$209K Buy
+4,040
New +$205K 0.07% 99

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return